World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
114
Citations
47636
World Ranking
4739
National Ranking
2567

Edward A. Sausville publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Edward A. Sausville sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 422 publications — 43rd percentile

43% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Edward A. Sausville D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Edward A. Sausville sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 114 D-Index — 77th percentile

77% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Edward A. Sausville is affiliated with the University of Maryland, Baltimore in the United States. Their research spans multiple fields including Medicine and Biochemistry, Genetics and Molecular Biology, with a focus on several specialized subfields such as Molecular Biology, Oncology, Hepatology, Pulmonary and Respiratory Medicine, and Pathology and Forensic Medicine.

The primary topics covered in their work involve hepatocellular carcinoma treatment and prognosis, cell death mechanisms and regulation, pancreatic and hepatic oncology research, sarcoma diagnosis and treatment, CAR-T cell therapy research, lymphoma diagnosis and treatment, and viral-associated cancers and disorders.

Some of their recent publications include:

  • Phase 1 trial of navitoclax and sorafenib in patients with relapsed or refractory solid tumors with hepatocellular carcinoma expansion cohort, 2024, Investigational New Drugs
  • Results of an Integrated Phase I/II Prospective Clinical Trial (NEXIS) for Neoadjuvant Anti-PD-L1 (Durvalumab) and Anti-CTLA-4 (Tremelimumab) With Radiation for High-Risk Soft-Tissue Sarcoma of the Trunk and Extremities, 2024, Cureus
  • Inhibition of Mitochondrial Respiration as a Source of Adaphostin-induced Reactive Oxygen Species and Cytotoxicity, 2021, UNC Libraries
  • Replacement of Antiretroviral Therapy with HIV Broadly Neutralizing Antibodies to Maximize the Effectiveness of Chemotherapy in HIV Patients with Lung Cancer, 2023, AIDS Research and Human Retroviruses
  • Editor's Note: Antiangiogenic Properties of 17-(Dimethylaminoethylamino)-17-Demethoxygeldanamycin: An Orally Bioavailable Heat Shock Protein 90 Modulator, 2024, Clinical Cancer Research

Frequent coauthors in their research include:

  • Scott H. Kaufmann
  • Oluwadunni E. Emiloju
  • Jun Yin
  • Emily J. Koubek
  • Joel M. Reid

Edward A. Sausville has published regularly in journals such as:

  • Investigational New Drugs
  • Cureus
  • UNC Libraries
  • AIDS Research and Human Retroviruses
  • Clinical Cancer Research

Best Publications

  • Proteasome Inhibitors: A Novel Class of Potent and Effective Antitumor Agents

    Julian Adams;Vito J. Palombella;Edward A. Sausville;Jill Johnson

  • A gene expression database for the molecular pharmacology of cancer

    Uwe Scherf;Douglas T. Ross;Mark Waltham;Lawrence H. Smith

  • An Information-Intensive Approach to the Molecular Pharmacology of Cancer

    John N. Weinstein;Timothy G. Myers;Patrick M. O'Connor;Stephen H. Friend

  • L-myc, a new myc-related gene amplified and expressed in human small cell lung cancer.

    Marion M. Nau;Burke J. Brooks;James Battey;Edward Sausville

  • Flavopiridol Induces G1 Arrest with Inhibition of Cyclin-dependent Kinase (CDK) 2 and CDK4 in Human Breast Carcinoma Cells

    Bradley A. Carlson;Marja M. Dubay;Edward A. Sausville;Leonardo Brizuela

  • Issues and progress with protein kinase inhibitors for cancer treatment

    Janet Dancey;Edward A. Sausville

  • Osteonecrosis of the Jaw in Multiple Myeloma Patients: Clinical Features and Risk Factors

    Ashraf Badros;Dianna Weikel;Andrew Salama;Olga Goloubeva

  • Preclinical and Clinical Development of Cyclin-Dependent Kinase Modulators

    Adrian M. Senderowicz;Edward A. Sausville

  • Novel Proteasome Inhibitor PS-341 Inhibits Activation of Nuclear Factor-κB, Cell Survival, Tumor Growth, and Angiogenesis in Squamous Cell Carcinoma

    John B. Sunwoo;Zhong Chen;Gang Dong;Ning Yeh

  • The Chk1 protein kinase and the Cdc25C regulatory pathways are targets of the anticancer agent UCN-01

    Paul R. Graves;Lijia Yu;Julie K. Schwarz;Janis Gales

  • UCN-01: a Potent Abrogator of G2 Checkpoint Function in Cancer Cells With Disrupted p53

    Qizhi Wang;Saijun Fan;Alan Eastman;Peter J. Worland

  • Identification of Small Molecule Inhibitors of Hypoxia-inducible Factor 1 Transcriptional Activation Pathway

    Annamaria Rapisarda;Badarch Uranchimeg;Dominic A. Scudiero;Mike Selby

  • Contributions of Human Tumor Xenografts to Anticancer Drug Development

    Edward A. Sausville;Angelika M. Burger

  • A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides.

    Kaye Fj;Bunn Pa;Steinberg Sm;Stocker Jl

  • Perifosine, a novel alkylphospholipid, inhibits protein kinase B activation

    Sudhir B Kondapaka;Sheo S Singh;Girija P Dasmahapatra;Edward A Sausville

  • Small-molecule antagonists of apoptosis suppressor XIAP exhibit broad antitumor activity.

    Aaron D. Schimmer;Kate Welsh;Clemencia Pinilla;Zhiliang Wang

  • Synthesis and biological evaluation of novel curcumin analogs as anti-cancer and anti-angiogenesis agents

    Brian K. Adams;Eva M. Ferstl;Matthew C. Davis;Marike Herold

  • Phase I trial of continuous infusion flavopiridol, a novel cyclin-dependent kinase inhibitor, in patients with refractory neoplasms.

    A M Senderowicz;D Headlee;S F Stinson;R M Lush

  • Phase I and Pharmacokinetic Study of MS-275, a Histone Deacetylase Inhibitor, in Patients With Advanced and Refractory Solid Tumors or Lymphoma

    Qin C. Ryan;Donna Headlee;Milin Acharya;Alex Sparreboom

  • Genomic-scale measurement of mRNA turnover and the mechanisms of action of the anti-cancer drug flavopiridol.

    Lloyd T Lam;Oxana K Pickeral;Amy C Peng;Andreas Rosenwald

Frequent Co-Authors

William D. Figg
William D. Figg National Institutes of Health
Patricia LoRusso
Patricia LoRusso Yale University
Maria R. Baer
Maria R. Baer University of Maryland, Baltimore
Jane B. Trepel
Jane B. Trepel National Institutes of Health
Robert H. Shoemaker
Robert H. Shoemaker National Institutes of Health
Dominic A. Scudiero
Dominic A. Scudiero Science Applications International Corporation (United States)
Robert R. Redfield
Robert R. Redfield Centers for Disease Control and Prevention
Alex Sparreboom
Alex Sparreboom The Ohio State University
Christopher P. Leamon
Christopher P. Leamon Fusion Pharmaceuticals
Laurent Meijer
Laurent Meijer Perha Pharmaceuticals

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine opens doors to a variety of related fields and flexible online degree options. Many healthcare professionals start their journey with an Associate Degree in Nursing. For those wishing to advance, adn to np programs offer a seamless bridge to nurse practitioner roles, often without pausing work.

Nutrition is another fast-growing sector closely tied to healthcare. An online bachelor's in nutrition provides foundational knowledge in dietetics, health promotion, and wellness, leading to diverse career opportunities in community health and clinical settings.

For those drawn to leadership, the best mha programs equip students with essential management and administrative skills for hospitals or healthcare organizations—all delivered in a flexible online format.

Registered nurses seeking career advancement can benefit from rn bsn online programs no clinicals, which make it possible to earn a Bachelor of Science in Nursing without on-site clinical requirements, allowing for greater adaptability and career growth.

Best Scientists Citing Edward A. Sausville

Trending Scientists

Recently Published Articles